nestle glp 1 products may complement GLP-1 weight-loss drugs GLP‑1 Disruption, Nestlé's Strategy Shift

Saltiel AR, Kahn CR

Sci Rep 2024

10.1111/obr.12465 [DOI] [PubMed] 2.Leitner DR et al (2017) Obesity and type 2 diabetes: two diseases with a need for combined treatment strategiesEASO Can lead the way

It is a legitimate commitment, and one you should make with full awareness of what the adjustment period looks like

It also influences how your body stores fat

At the end of the study, patients who had metabolic surgery had a: 32% lower risk of death 35% lower risk of major heart problems (such as heart attack, heart failure, or stroke) 47% lower risk of serious kidney disease 54% lower risk of diabetes-related eye damage (retinopathy) On average, people who had metabolic surgery lost 21.6% of their body weight over 10 years, compared with 6.8% weight loss in people who took GLP-1 medicines